Logo image of ABAT

AMERICAN BATTERY TECHNOLOGY (ABAT) Stock Fundamental Analysis

USA - NASDAQ:ABAT - US02451V3096 - Common Stock

6.1 USD
-0.62 (-9.23%)
Last: 10/21/2025, 8:00:00 PM
5.81 USD
-0.29 (-4.75%)
After Hours: 10/21/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, ABAT scores 3 out of 10 in our fundamental rating. ABAT was compared to 155 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for ABAT as it has an excellent financial health rating, but there are worries on the profitability. ABAT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ABAT has reported negative net income.
In the past year ABAT has reported a negative cash flow from operations.
In the past 5 years ABAT always reported negative net income.
ABAT had a negative operating cash flow in each of the past 5 years.
ABAT Yearly Net Income VS EBIT VS OCF VS FCFABAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

ABAT's Return On Assets of -55.47% is on the low side compared to the rest of the industry. ABAT is outperformed by 91.61% of its industry peers.
The Return On Equity of ABAT (-66.36%) is worse than 85.81% of its industry peers.
Industry RankSector Rank
ROA -55.47%
ROE -66.36%
ROIC N/A
ROA(3y)-50.51%
ROA(5y)-82.28%
ROE(3y)-62.17%
ROE(5y)-93.78%
ROIC(3y)N/A
ROIC(5y)N/A
ABAT Yearly ROA, ROE, ROICABAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10K -20K -30K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ABAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABAT Yearly Profit, Operating, Gross MarginsABAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K

More info and screens

7

2. Health

2.1 Basic Checks

ABAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABAT has been increased compared to 1 year ago.
The number of shares outstanding for ABAT has been increased compared to 5 years ago.
ABAT has a worse debt/assets ratio than last year.
ABAT Yearly Shares OutstandingABAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ABAT Yearly Total Debt VS Total AssetsABAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

ABAT has an Altman-Z score of 28.67. This indicates that ABAT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 28.67, ABAT belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
There is no outstanding debt for ABAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 28.67
ROIC/WACCN/A
WACC8.92%
ABAT Yearly LT Debt VS Equity VS FCFABAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

ABAT has a Current Ratio of 2.16. This indicates that ABAT is financially healthy and has no problem in meeting its short term obligations.
ABAT has a Current ratio of 2.16. This is comparable to the rest of the industry: ABAT outperforms 45.81% of its industry peers.
A Quick Ratio of 2.13 indicates that ABAT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.13, ABAT is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 2.13
ABAT Yearly Current Assets VS Current LiabilitesABAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

ABAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.74%, which is quite impressive.
The Revenue has grown by 1149.00% in the past year. This is a very strong growth!
EPS 1Y (TTM)47.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)1149%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%708.15%

3.2 Future

The Earnings Per Share is expected to grow by 37.86% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 183.27% on average over the next years. This is a very strong growth
EPS Next Y29.1%
EPS Next 2Y37.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-50.02%
Revenue Next 2Y183.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ABAT Yearly Revenue VS EstimatesABAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 10M 20M 30M 40M
ABAT Yearly EPS VS EstimatesABAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ABAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ABAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABAT Price Earnings VS Forward Price EarningsABAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABAT Per share dataABAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ABAT's earnings are expected to grow with 37.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.86%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ABAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN BATTERY TECHNOLOGY

NASDAQ:ABAT (10/21/2025, 8:00:00 PM)

After market: 5.81 -0.29 (-4.75%)

6.1

-0.62 (-9.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-18 2025-09-18/dmh
Earnings (Next)11-12 2025-11-12
Inst Owners19.03%
Inst Owner Change0.04%
Ins Owners5.53%
Ins Owner Change29.68%
Market Cap720.11M
Analysts82.86
Price Target6.12 (0.33%)
Short Float %13.92%
Short Ratio1.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.81%
Min Revenue beat(2)-97.13%
Max Revenue beat(2)118.76%
Revenue beat(4)1
Avg Revenue beat(4)-43.82%
Min Revenue beat(4)-98.52%
Max Revenue beat(4)118.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 167.84
P/FCF N/A
P/OCF N/A
P/B 10.2
P/tB 10.31
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.04
BVpS0.6
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.47%
ROE -66.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.51%
ROA(5y)-82.28%
ROE(3y)-62.17%
ROE(5y)-93.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.52%
Cap/Sales 59.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.16
Quick Ratio 2.13
Altman-Z 28.67
F-Score6
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)5215.47%
Cap/Depr(5y)23321.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y29.1%
EPS Next 2Y37.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1149%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%708.15%
Revenue Next Year-50.02%
Revenue Next 2Y183.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.81%
OCF growth 3YN/A
OCF growth 5YN/A